Portfolio 2014

Company: Encare Biotech - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2014
Status: Active

Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.